PANews reported on September 22nd, according to 21CBR , that Huajian Medical announced the completion of the Nanjing ETHK Building, positioning itself as the world's first dedicated R&D base for digital real-world assets ( RWAs ). Since July , Huajian Medical has acquired a controlling stake in Guofu Quantum and established an innovative drug intellectual property tokenization fund, increasing its market capitalization from HK$ 3 billion to HK$ 17 billion. The company has been renamed "Huajian Digital Industry Group" and is collaborating with Renhe Pharmaceutical to establish an OTC drug RWA exchange in the United States, promoting the digitization and on-chain circulation of medical assets.PANews reported on September 22nd, according to 21CBR , that Huajian Medical announced the completion of the Nanjing ETHK Building, positioning itself as the world's first dedicated R&D base for digital real-world assets ( RWAs ). Since July , Huajian Medical has acquired a controlling stake in Guofu Quantum and established an innovative drug intellectual property tokenization fund, increasing its market capitalization from HK$ 3 billion to HK$ 17 billion. The company has been renamed "Huajian Digital Industry Group" and is collaborating with Renhe Pharmaceutical to establish an OTC drug RWA exchange in the United States, promoting the digitization and on-chain circulation of medical assets.

Huajian Medical, which has deployed RWA digital assets, saw its market value surge by HK$14 billion in two months.

2025/09/22 08:49

PANews reported on September 22nd, according to 21CBR , that Huajian Medical announced the completion of the Nanjing ETHK Building, positioning itself as the world's first dedicated R&D base for digital real-world assets ( RWAs ). Since July , Huajian Medical has acquired a controlling stake in Guofu Quantum and established an innovative drug intellectual property tokenization fund, increasing its market capitalization from HK$ 3 billion to HK$ 17 billion. The company has been renamed "Huajian Digital Industry Group" and is collaborating with Renhe Pharmaceutical to establish an OTC drug RWA exchange in the United States, promoting the digitization and on-chain circulation of medical assets.

Market Opportunity
DAR Open Network Logo
DAR Open Network Price(D)
$0.01394
$0.01394$0.01394
-8.40%
USD
DAR Open Network (D) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.